Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.
نویسندگان
چکیده
Intravesical instillation of thiotepa is a popular treatment for localized bladder carcinoma. The drug can enter the systemic circulation, and such absorption may be enhanced by extensive tumour infiltration or by a recent tumour resection. A case is reported of early onset life-threatening pancytopenia following an unusually low dose of the drug in a patient who had undergone a recent tumour resection.
منابع مشابه
Intravesical Therapy and Follow-up of Superficial Transitional Cell Carcinoma of the Bladder
Intravesical therapy is commonly used for the treatment of superficial transitional cell carcinoma (TCC) of the bladder. There are 2 major categories of intravesical therapy; chemotherapy and immunotherapy. The 2 types have different indications and different mechanisms of action. Chemotherapy: there is evidence that intravesical therapy fails to affect disease progression, nevertheless, chemot...
متن کاملThiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.
OBJECTIVE The efficacy of intravesical thiotepa was evaluated compared with administration of Bacille Calmette-Guérin (BCG) in non-muscle invasive bladder cancer. PATIENTS In this multicenter, prospective, randomized study, eligible patients were those with proven non-muscle invasive bladder cancer. All patients were randomly allocated to Group A, receiving intravesical thiotepa (at a dose of...
متن کاملFactors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases
OBJECTIVE Severe myelosuppression is a serious concern in the management of rheumatic disease patients receiving methotrexate (MTX) therapy. This study was intended to explore factors associated with the development of MTX-related myelosuppression and its disease severity. METHODS We retrospectively examined a total of 40 cases of MTX-related myelosuppression that had been filed in the regist...
متن کاملSuccessful autologous peripheral blood stem cell transplantation using thiotepa in a patient with systemic sclerosis and cardiac involvement.
A 19-year-old man with systemic sclerosis (SSc) was hospitalized for autologous peripheral blood stem cell transplantation (auto-PBSCT) due to progressive scleroderma and cardiac involvement despite conventional treatment. During the administration of cyclophosphamide (60 mg/kg/day for 2 days) for mobilization and collection of CD34+ selected peripheral blood stem cells, he developed congestive...
متن کاملClinical dilemma over low-dose methotrexate therapy in dialysis patients: a case report and review of literature.
Myelosuppression is the life-threatening adverse effect of methotrexate. Impaired kidney function is a major aggravating factor of methotrexate-induced myelosuppression. In end-stage renal disease patients, methotrexate therapy must be with cautious because the efficacy of removal of methotrexate by means of dialysis is in doubt. In clinical practice, low-dose methotrexate is still used by clin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Postgraduate medical journal
دوره 58 680 شماره
صفحات -
تاریخ انتشار 1982